US Broker Ratings

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Potential Upside Amidst Non-Opioid Innovation

Pacira BioSciences, Inc. (PCRX) is a name that individual investors in the healthcare sector should keep on their radar. Known for its innovative approach to non-opioid..

Teladoc Health, Inc. (TDOC): Investor Outlook on a Healthcare Innovator with an 11.42% Upside Potential

Teladoc Health, Inc. (TDOC), a leader in virtual healthcare services, is facing a dynamic landscape in the health information services industry. With a current market capitalization..

GRAIL, Inc. (GRAL) Investor Outlook: A Healthcare Innovator with a $1.6 Billion Market Cap

GRAIL, Inc. (GRAL), a pioneering force in the healthcare sector, is making waves with its advanced diagnostics and research solutions. Headquartered in Menlo Park, California, this..

HUTCHMED (China) Limited (HCM) Stock Analysis: A 35.31% Upside Potential Amidst Healthcare Innovations

HUTCHMED (China) Limited (NASDAQ: HCM) is carving a niche in the global healthcare sector, focusing on the discovery and commercialization of targeted therapeutics and immunotherapies. Despite..

Janux Therapeutics, Inc. (JANX): Investor Outlook on a Biotech with a 234% Potential Upside

As investors navigate the complex landscape of biotechnology stocks, Janux Therapeutics, Inc. (NASDAQ: JANX) emerges as a compelling candidate for those seeking high-growth potential. With its..

Kestra Medical Technologies (KMTS) Stock Analysis: Impressive Revenue Growth with Significant Upside Potential

Investors eyeing the healthcare sector should pay close attention to Kestra Medical Technologies, Ltd. (KMTS), a dynamic player in the medical instruments and supplies industry. With..

Surgery Partners, Inc. (SGRY): Investor Outlook on a Potential 40.92% Upside

Surgery Partners, Inc. (NASDAQ: SGRY) has positioned itself as a significant player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood,..

NeoGenomics, Inc. (NEO) Stock Analysis: Uncovering a Potential 19% Upside in the Diagnostics Sector

NeoGenomics, Inc. (NEO), a prominent player in the healthcare sector, has carved a niche in the diagnostics and research industry with its specialized cancer-focused testing laboratories...

Integra LifeSciences Holdings (IART) Stock Analysis: A Deep Dive into its 10.17% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, operates within the specialized industry of medical devices. Headquartered in Princeton, New Jersey,..

10x Genomics, Inc. (TXG) Stock Analysis: Unpacking a 15.58% Potential Upside for Investors

Investors with a keen eye on the healthcare sector might find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing prospect. With its specialized focus on health information..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating the CNS Drug Maker’s Market Position and Growth Potential

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a notable player in the healthcare sector specializing in drug manufacturing for central nervous system (CNS) diseases, has been capturing investor..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a Potential 88% Upside in the Biotech Space

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneer in the field of biotechnology, is capturing investor attention with its innovative approach to precision genetic medicines. Headquartered in..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Leading Biotech with an 8.75% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to developing peptide therapeutics for complex..

Privia Health Group, Inc. (PRVA): Investor Outlook Reveals 32% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA), a noted player in the healthcare sector, is drawing significant investor attention with its promising growth prospects and strategic positioning..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Analyst Consensus Pointing to a 23.81% Upside

BioLife Solutions, Inc. (NASDAQ: BLFS) operates at the fascinating intersection of healthcare and technology, specifically within the medical instruments and supplies industry. With a market capitalization..

Brookdale Senior Living Inc. (BKD): Investor Outlook Amidst Strong Revenue Growth and Challenging Valuations

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specializes in providing senior living communities across the United States. Despite its extensive..

Novavax, Inc. (NVAX) Stock Analysis: Assessing a 40.92% Potential Upside in the Biotech Sector

Investors keen on exploring opportunities in the biotechnology sector should consider Novavax, Inc. (NASDAQ: NVAX), a company renowned for its innovative vaccine technologies. Headquartered in Gaithersburg,..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring Upside Potential with a 16.80% Revenue Growth

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) presents an intriguing opportunity for investors interested in the healthcare sector, particularly within the medical care facilities industry. This Atlanta-based..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Unpacking a 47% Upside Potential

Investors with an eye for growth opportunities in the biotech sector might find Xenon Pharmaceuticals Inc. (NASDAQ: XENE) an intriguing prospect. With a market cap of..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 25% Potential Upside Awaits Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, is garnering attention from investors with a tantalizing 25% potential upside. As a global biopharmaceutical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds